
TG THERAPEUTICS, INC.
TG THERAPEUTICS, INC. (TGTX)
WebsitePrice
Market cap
Next catalystExpected 2026BRIUMVI (ublituximab-xiiy) · Trial initiationCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved